The global wearable injectors market size was valued at USD 2.9 billion in 2016 and is expected to grow at a CAGR of 16.4% during the forecast period. Growing geriatric population & prevalence of chronic diseases coupled with increasing concern about needle stick injuries are expected boost the wearable injectors market during the forecast period. In addition, rising demand for round-the-clock monitoring and need to reduce healthcare costs are also expected support market growth.
Growing geriatric population, coupled with rising prevalence of chronic diseases, such as cancer, diabetes,neurological disorders, hypertension, and age-related orthopedic disorders, is also expected to facilitate growth. The WHO estimates that global population aged 60 years and above will rise from 841.0 million in 2013 to over 2.0 billion by 2050.
U.S. wearable injectors market, by technology, 2014 - 2025 (USD Million)
According to the WHO’s World Health Report 2002, around 2.0 million healthcare workers out of a total of 35.0 million, experience percutaneous exposure to infectious diseases every year. The report further states that worldwide, about 39.0% of patients suffering from Hepatitis C, 37.6% of those suffering from hepatitis B, and 4.4% of those suffering from HIV/AIDS are healthcare workers. Wearable injectors provide higher safety for patients and healthcare workers by eliminating risks related to conventional infusion and injection technology, such as drug preparation, needle insertion, covering, and needles’ disposal.
With technological advancements in injectors, a needle is never exposed to the patient. The needle is inserted after the injector is attached and the button is pressed. Once the drug is released, the needle automatically retracts and gets locked out, thereby enabling safe and convenient disposal of the system, and the patient is notified with tactile, audible, and visual signals. With the use of wearable injectors, there would be no needle stick injuries as compared to intravenous injectables and parenteral administration.
Rise in healthcare costs is one of the biggest concerns faced by developing and developed regions. These regions are struggling to develop cost-effective and quality care. With the help of wearable injectors, patients can self-administer the wearable injector at home subcutaneously. This is expected to reduce the number of visits to hospitals or other healthcare settings, thereby reducing healthcare expenses.
The types analyzed in this study include on-body and off-body wearable injectors. The on-body segment is expected to dominate the market owing to increased demand, as these patches are comfortable to wear on the skin (stomach). They are also water resistant and convenient to use at home.
The benefits of on-body wearable injectors are:
Decreased healthcare costs (decrease number of visits to hospitals)
Lifecycle management (intravenous to subcutaneous)
Changes in dosage frequency
Automatic warming of refrigerated drug
The off-body segment is expected to register favorable growth over the forecast period as these devices eliminate risks, such as painful removal of devices, adhesive fitting issues to the skin, and skin sensitivity or irritation.
The technologies analyzed in this study include spring-based, motor-driven, rotary pump, expanding battery, and others. The spring-based segment is anticipated to dominate the market, owing to rising demand for adhesive patches, as these devices are user-friendly and enable patients to accurately deliver the drug subcutaneously by pressing one or more buttons on the device.
The motor-driven segment is expected to register comparatively higher CAGR over the forecast period, due to increasing customer demand for these devices as they are more convenient for use, as compared to others.
Applications analyzed in this study include oncology, infectious, cardiovascular, & autoimmune diseases, and others. The oncology segment is likely to dominate the market owing to rising prevalence of cancer coupled with increasing shift toward self-administration of medication among patients.
The autoimmune disease segment is expected to be the fastest-growing segment over the forecast period due to rising prevalence of diabetes and increasing adoption of wearable injectors due to their competitive advantage over insulin pumps.
The end-use segment is categorized into hospitals, clinics, home care, and others. The home care segment is expected to dominate, due to the rising preference for self-administration of medication and increasing need to curb healthcare costs. In addition, growing demand for technologically developed drug delivery, which lowers hospitalization rate and requires minimal expertise, is expected to boost the market.
On the other hand, the hospital segment is expected to exhibit lucrative growth during the forecast period owing to increased number of patients that require hospitalization. Also, the increasing number of hospitals across the globe is anticipated to drive the demand for this market.
Global wearable injectors market, by region, 2016 (%)
North America held over 40.00% share in the market in 2016, owing to rising prevalence of chronic & lifestyle-related diseases and presence of sophisticated healthcare infrastructure. In addition, local presence of major market players in the U.S., such as Becton, Dickinson and Company; Johnson & Johnson Services, Inc.; Unilife Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; and Enable Injections, is expected to boost the market.
Europe is also expected to hold a substantial market share during the forecast period due to the flourishing medical device industry in the UK, Germany, and France coupled with increasing avenues for market players in this region.
Asia Pacific is expected to register higher CAGR over the forecast period as compared to other regions, which can be attributed to favorable government initiatives for the use of medical devices such as wearable injectors, increasing geriatric population, and increasing healthcare expenditure in this region.
Some of the major players in this space include Becton, Dickinson and Company; Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche Ltd.; Unilife Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet Corporation; Enable Injections; West Pharmaceutical Services, Inc.; and CeQur SA.
These players focus on growth strategies, such as new product launches, collaborations, partnerships, operational expansion, mergers & acquisitions, and patient awareness campaigns. For instance, in June 2014, SteadyMed Therapeutics, Inc. partnered with Bespak Europe Ltd., a European manufacturer of medical devices, to develop and manufacture Trevyent (an injector with PatchPump-based platform that works on an expanding battery to take the drug out of a flexible primary drug container).
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2025
Revenue in USD Million & CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America, & MEA
U.S., Canada, UK, Germany, France, Japan, China, Brazil, Mexico, and South Africa
Revenue, competitive landscape, growth factors, and trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
Segments Covered in the Report
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the wearable injectors market on the basis of type, technology, application, end use, and region:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Technology Outlook (Revenue, USD Million, 2014 - 2025)
Application Outlook (Revenue, USD Million, 2014 - 2025)
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East and Africa (MEA)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.